The Memo: Fluid Biomed Pioneering Bioabsorbable Stents to Cure Brain Aneurysms

Under the direction of two neurosurgeon founders with expertise in patient care, biomedical engineering, and clinical trials, Fluid Biomed is redefining the treatment of brain aneurysms with the world’s first bioabsorbable polymer-based stent. Unlike traditional metal stents, which remain permanently in the body and require lifelong blood thinners, Fluid Biomed’s innovation slowly dissolves, allowing blood vessels to progressively heal. This blog is originally published here: https://www.lifesciencemarketr....esearch.com/insights

Cell Delivery Catheters Market Snapshot

This market snapshot from Life Science Intelligence provides an analysis of the global market for cell delivery catheters. These devices are primarily research-use devices for the delivery of cellular therapies for the treatment of chronic diseases, such as cardiovascular disease and cancer. For more information visit https://www.lifesciencemarketr....esearch.com/market-r

The Memo: Two Frontiers of Innovation—XCath and EndoQuest Robotics

XCath and EndoQuest Robotics share a common origin, both spinning out of the University of Texas Microsurgical Robotics Lab in 2017. Initially part of the same research initiative, the two companies eventually diverged into separate commercial entities, each focusing on a distinct technological application. This blog is originally published here: https://www.lifesciencemarketr....esearch.com/insights

The Weekly Recap 2/14/25: LSI Alumni Achievements Driving Medtech and Healthtech Forward

In a successful week for the medical technology companies in the LSI Alumni community, we saw LSI Alumni obtain regulatory approvals, secure over $41M in new funds, form new partnerships, and much more on the road to LSI USA ‘25 in Dana Point, CA (March 17-21). This blog is originally published here: https://www.lifesciencemarketr....esearch.com/insights

The Memo: Spiro Robotics Pioneering the Future of Tracheal Intubation

More than 30 million OR, ICU, and ED intubations are performed annually in the U.S. alone, and over 6 million are estimated to be difficult. Difficult intubations are often managed poorly, which can result in varying degrees of airway trauma, airway obstruction, hypoxia (lack of oxygen), and even brain damage and death. This blog is originally published here: https://www.lifesciencemarketr....esearch.com/insights